Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.63 EUR | -0.22% | +6.19% | -12.97% |
2023 | Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2023 * | 60.6M 64.5M | Sales 2024 * | 63.8M 67.9M | Capitalization | 12.91M 13.74M |
---|---|---|---|---|---|
Net income 2023 * | - 0 | Net income 2024 * | 1M 1.06M | EV / Sales 2023 * | -0.13 x |
Net cash position 2023 * | 21M 22.35M | Net cash position 2024 * | 22.1M 23.52M | EV / Sales 2024 * | -0.14 x |
P/E ratio 2023 * |
18.5
x | P/E ratio 2024 * |
11.3
x | Employees | 190 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 35.31% |
1 day | -0.22% | ||
1 week | +6.19% | ||
Current month | +10.77% | ||
1 month | +3.58% | ||
3 months | -13.62% | ||
6 months | -3.14% | ||
Current year | -12.97% |
Managers | Title | Age | Since |
---|---|---|---|
Mathieu Roturier
CEO | Chief Executive Officer | 47 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mathieu Roturier
CEO | Chief Executive Officer | 47 | - |
Francky Défossé
BRD | Director/Board Member | 37 | - |
Joseph Asselin
BRD | Director/Board Member | 50 | 17-03-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 4.63 | -0.22% | 121 |
24-04-17 | 4.64 | +0.87% | 537 |
24-04-16 | 4.6 | +1.55% | 470 |
24-04-15 | 4.53 | +3.66% | 1,187 |
24-04-12 | 4.37 | +0.23% | 1,442 |
Real-time Euronext Paris, April 18, 2024 at 04:12 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.97% | 13.76M | |
-4.36% | 184B | |
-3.87% | 105B | |
-4.38% | 67.09B | |
+8.23% | 51.61B | |
+15.54% | 47.55B | |
+0.60% | 39.95B | |
+7.16% | 27.62B | |
-12.48% | 25.74B | |
-1.68% | 25.62B |
- Stock Market
- Equities
- ALEMG Stock